These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 21255574)
1. Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG. Kwong AD; Najera I; Bechtel J; Bowden S; Fitzgibbon J; Harrington P; Kempf D; Kieffer TL; Koletzki D; Kukolj G; Lim S; Pilot-Matias T; Lin K; Mani N; Mo H; O'Rear J; Otto M; Parkin N; Pawlotsky JM; Petropoulos C; Picchio G; Ralston R; Reeves JD; Schooley RT; Seiwert S; Standring D; Stuyver L; Sullivan J; Miller V; ; ; ; Gastroenterology; 2011 Mar; 140(3):755-60. PubMed ID: 21255574 [No Abstract] [Full Text] [Related]
2. Resistance to direct antiviral agents in patients with hepatitis C virus infection. Sarrazin C; Zeuzem S Gastroenterology; 2010 Feb; 138(2):447-62. PubMed ID: 20006612 [TBL] [Abstract][Full Text] [Related]
3. Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b. Saito T; Ito T; Ishiko H; Yonaha M; Morikawa K; Miyokawa A; Mitamura K Am J Gastroenterol; 2003 Jun; 98(6):1377-83. PubMed ID: 12818284 [TBL] [Abstract][Full Text] [Related]
4. Designing a low-cost drug resistance database for viral hepatitis. Kuiken C Antivir Ther; 2010; 15(3 Pt B):517-20. PubMed ID: 20516573 [TBL] [Abstract][Full Text] [Related]
5. Association with 5'-untranslated region and response to interferon in chronic hepatitis C. Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H Hepatogastroenterology; 2007; 54(75):854-7. PubMed ID: 17591078 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment. Torres-Puente M; Cuevas JM; Jiménez-Hernández N; Bracho MA; García-Robles I; Carnicer F; del Olmo J; Ortega E; Moya A; González-Candelas F J Med Virol; 2008 Feb; 80(2):247-53. PubMed ID: 18098147 [TBL] [Abstract][Full Text] [Related]
7. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon. Boulestin A; Kamar N; Sandres-Sauné K; Legrand-Abravanel F; Alric L; Vinel JP; Rostaing L; Izopet J J Med Virol; 2006 Mar; 78(3):365-71. PubMed ID: 16419107 [TBL] [Abstract][Full Text] [Related]
8. Management strategies using pharmacogenomics in patients with severe HCV-1b infection: a decision analysis. Moriguchi H; Uemura T; Kobayashi M; Chung RT; Sato C Hepatology; 2002 Jul; 36(1):177-85. PubMed ID: 12085363 [TBL] [Abstract][Full Text] [Related]
9. Analysis of sequence configurations of the PKR-interacting HCV proteins from plasma and PBMC as predictors of response to interferon-alpha and ribavirin therapy in HIV-coinfected patients. Bolcic F; Bull L; Martinez L; Reynoso R; Salomon H; Arduino R; Barnett B; Quarleri J Intervirology; 2008; 51(4):261-4. PubMed ID: 18824873 [No Abstract] [Full Text] [Related]
10. Mechanism of interferon resistance in hepatitis C. Gretch D Lancet; 2001 Nov; 358(9294):1662-4. PubMed ID: 11728538 [No Abstract] [Full Text] [Related]
11. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same. Herion D; Hoofnagle JH Hepatology; 1997 Mar; 25(3):769-71. PubMed ID: 9049233 [No Abstract] [Full Text] [Related]
12. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Chayama K; Tsubota A; Kobayashi M; Okamoto K; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Kumada H Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229 [TBL] [Abstract][Full Text] [Related]